Science Explorer Back to mapMap
Discussion

TherimuneX Pharmaceuticals (United States)

Research works
8
▲ 52% vs 2018-21
Citations
171
22.2 per fractional work
Top-10% rate
0.0%
all institutions 10.0%
Open access
47%
world 40%
International
6%
world 18%
TherimuneX Pharmaceuticals (United States)

Not ranked overall: TherimuneX Pharmaceuticals (United States) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does TherimuneX Pharmaceuticals (United States) work in?

In all years, 58% of research at TherimuneX Pharmaceuticals (United States) is in Life Sciences, 35% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (34%), Medicine (33%), Immunology and Microbiology (19%). It does 1.8× the world's share of Life Sciences.

Life Sciences: 4 fractional works · 58.1% of its workBiochemistry, Genetics and Molecular Biology: 3 fractional works · 34.5% of its workMolecular Biology: 2 fractional works · 29.3% of its workMolecular Medicine: 0 fractional works · 2.2% of its workCancer Research: 0 fractional works · 1.4% of its workBiophysics: 0 fractional works · 1.0% of its workCell Biology: 0 fractional works · 0.5% of its workImmunology and Microbiology: 1 fractional works · 19.2% of its workImmunology: 1 fractional works · 12.5% of its workMicrobiology: 0 fractional works · 5.7% of its workVirology: 0 fractional works · 1.0% of its workAgricultural and Biological Sciences: 0 fractional works · 3.9% of its workAnimal Science and Zoology: 0 fractional works · 1.0% of its workPlant Science: 0 fractional works · 1.0% of its workAgronomy and Crop Science: 0 fractional works · 0.9% of its workEcology, Evolution, Behavior and Systematics: 0 fractional works · 0.9% of its workNeuroscience: 0 fractional works · 0.5% of its workBiological Psychiatry: 0 fractional works · 0.5% of its workHealth Sciences: 3 fractional works · 35.1% of its workMedicine: 3 fractional works · 32.9% of its workEpidemiology: 1 fractional works · 10.7% of its workOncology: 0 fractional works · 6.5% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 5.5% of its workHepatology: 0 fractional works · 4.9% of its workInfectious Diseases: 0 fractional works · 3.3% of its workGeriatrics and Gerontology: 0 fractional works · 2.2% of its workHealth Professions: 0 fractional works · 2.2% of its workEmergency Medical Services: 0 fractional works · 2.2% of its workSocial Sciences: 0 fractional works · 4.3% of its workEconomics, Econometrics and Finance: 0 fractional works · 4.3% of its workEconomics and Econometrics: 0 fractional works · 4.3% of its workPhysical Sciences: 0 fractional works · 2.5% of its workChemistry: 0 fractional works · 2.5% of its workSpectroscopy: 0 fractional works · 1.4% of its workAnalytical Chemistry: 0 fractional works · 1.0% of its workALL ITS WORKTherimuneXPharmaceuticals…8fractional works, all years
Life Sciences58%Physical Sciences2%Health Sciences35%Social Sciences4%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 8 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology334.5%
    2. Immunology and Microbiology119.2%
    3. Agricultural and Biological Sciences03.9%
    4. Neuroscience00.5%
    1. Medicine332.9%
    2. Health Professions02.2%
    1. Economics, Econometrics and Finance04.3%
    1. Chemistry02.5%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

What are the most cited papers from TherimuneX Pharmaceuticals (United States)?

The most cited paper from TherimuneX Pharmaceuticals (United States) is "Deactivation of Akt and STAT3 signaling promotes apoptosis, inhibits proliferation, and enhances the sensitivity of hepatocellular carcinoma cells to an anticancer agent, Atiprimod" (Sweeta R. Choudhari, Muhammad Ajmal Khan, Genesis Harris et al., 2007), with 90 citations. Next come "Urotensin-II Receptor Modulators as Potential Drugs" (45) and "Targeting the unfolded protein response, XBP1, and the NLRP3 inflammasome in fibrosis and cancer" (31).

Most cited papers
#PaperReleasedCitations
1 Deactivation of Akt and STAT3 signaling promotes apoptosis, inhibits proliferation, and enhances the sensitivity of hepatocellular carcinoma cells to an anticancer agent, Atiprimod Sweeta R. Choudhari, Muhammad Ajmal Khan, Genesis Harris et al. · Molecular Cancer Therapeutics 2007 90
2 Urotensin-II Receptor Modulators as Potential Drugs Bruce E. Maryanoff, William A. Kinney · Journal of Medicinal Chemistry Open access 31 Dec 2009 45
3 Targeting the unfolded protein response, XBP1, and the NLRP3 inflammasome in fibrosis and cancer Beth Overley-Adamson, Carol M. Artlett, Connie Stephens et al. · Cancer Biology & Therapy Open access 4 Feb 2014 31
4 NLRP3 Inflammasome Is a Target for Development of Broad-Spectrum Anti-Infective Drugs James D. Thacker, Brian Joseph Balin, Denah Marie Appelt et al. · Antimicrobial Agents and Chemotherapy Open access 31 Jan 2012 27
5 Influenza A(H5N1) Virus Subunit Vaccine Administered with CaPNP Adjuvant Induce High Virus Neutralization Antibody Titers in Mice Tülin Morçöl, Peri Nagappan, Stephen Bell et al. · AAPS PharmSciTech 7 Oct 2019 15
All 12 most cited papers, with filters and sorting

Which research topics does TherimuneX Pharmaceuticals (United States) publish most on?

By volume in 2022-now: PARP inhibition in cancer therapy, Autophagy in Disease and Therapy and Sirtuins and Resveratrol in Medicine.

  1. 1 PARP inhibition in cancer therapy Oncology 0 works
  2. 2 Autophagy in Disease and Therapy Epidemiology 0 works
  3. 3 Sirtuins and Resveratrol in Medicine Geriatrics and Gerontology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available47.0%not open53.0%

World: 40% of research is openly available.

with international co-authors5.8%domestic only94.2%

World: 18% is written across borders.

How has TherimuneX Pharmaceuticals (United States)'s research output changed?

Output in 2022-2025 was 52% higher than in 2018-2021.

201020152020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Doylestown

All research institutions in Doylestown

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about TherimuneX Pharmaceuticals (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.